Florida man back home after receiving second liver transplant at Chicago's Northwestern Medicine
Andrew Wagner traveled to Northwestern Medicine for a second liver transplant following his battle with stage 1 lung cancer. Wagner won the battle, but learned his transplanted liver from 15 years ago was failing.
As his condition got worse last year, his wife reached out to transplant centers across the country, hoping someone would agree to a second transplant. Since Wagner had not been cancer-free for three to five years, they were told the re-transplant was not an option.
When they traveled to Chicago, Northwestern Medicine agreed to the surgery.
"We're actually rewriting the textbook of indications for transplant here at Northwestern. It's really exciting times," said transplant surgeon Dr. Satish Nadig. "I always call this the renaissance of transplantation because what we're learning from the past is not necessarily what we're taking with us for the future of transplant."
Five months after surgery, Wagner's new liver is functioning well, and he remains cancer-free.
Now he's home with his wife, four daughters, and one granddaughter.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Global High-Throughput Screening Market to Surpass USD 50.2 Billion by 2029
Delray Beach, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) -- North America Leads Today, Asia Pacific to Record Fastest GrowthThe global high throughput screening market, valued at US$25.7 billion in 2023, stood at US$28.8 billion in 2024 and is projected to advance at a resilient CAGR of 11.8% from 2024 to 2029, culminating in a forecasted valuation of US$50.2 billion by the end of the period. This growth is propelled by surging R&D investments in drug discovery, strategic government funding, and the increasing adoption of automation in life sciences research. Download PDF Brochure: What Is Driving the Market Now?HTS adoption is accelerating due to innovations in automation, miniaturization, and high-content screening, which significantly reduce discovery timelines and enhance precision in identifying therapeutic candidates. Grants such as the USD 7.8 million awarded to the University of Pittsburgh for advanced drug discovery systems underscore growing institutional and government commitment to high-impact research. Why Does This Matter for Global Pharma and Biotech Leaders?The market represents a critical enabler for competitive advantage in lead discovery, target validation, compound profiling, and hit identification—processes essential for pipeline acceleration. While high instrument costs remain a barrier, particularly for automated liquid handling and high-resolution imaging systems, emerging markets such as China and India offer lucrative opportunities with strong government support and an expanding pharmaceutical manufacturing base. Who Are the Key Stakeholders?The HTS ecosystem spans pharmaceutical giants, biotechnology innovators, academic institutions, and technology providers, all collaborating to enhance assay development and manage the rising complexity of biological data. The consumables segment—driven by recurring purchases of reagents and kits—dominates the market, ensuring steady demand as HTS workflows expand globally. Request Sample Pages: Where Is Growth Coming From? North America currently leads, fueled by advanced HTS infrastructure, robust funding for life science research, and a thriving biotech sector. Asia Pacific is projected to be the fastest-growing region, supported by a diverse patient base, strong pharmaceutical capabilities, and favorable regulatory environments. How Are Market Leaders Responding? Thermo Fisher Scientific Inc. maintains global leadership through an extensive portfolio of automated systems, screening instruments, and consumables, underpinned by 3% annual R&D investment and strategic alliances. Agilent Technologies, Inc. offers highly customizable workflows via BioTek detection instruments and Gen6 software, strengthened by acquisitions such as e-MSion (US) to enhance mass spectrometry capabilities. Merck KGaA delivers a diverse portfolio of reagents, instruments, software, and services, leveraging global reach and deep customer relationships across pharma, academia, and government sectors. Market OutlookAs automation, AI-driven data analysis, and advanced assay development converge, HTS will remain at the forefront of pharmaceutical innovation. Decision-makers who strategically invest in HTS capabilities today will be best positioned to accelerate therapeutic pipelines, capture market share, and deliver faster, more targeted treatments to market. For more information, Inquire Now Discover Connected Healthcare Market Opportunities:Drug Screening MarketCarrier Screening MarketCell based Assays MarketLabel Free Detection MarketLife Science Instrumentation Market Get access to the latest updates on High-Throughput Screening Companies and High-Throughput Screening Market Size CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445, USA: +1-888-600-6441 Email: sales@ Visit Our Website: while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
8 minutes ago
- Yahoo
"Flesh-eating" bacteria risk increasing as ocean temperatures rise
Lifelong boat captain George Billiris says he's lucky to be alive after Vibrio vulnificus, the so-called "flesh-eating" bacteria that lurks in warm coastal waters like those along Florida's Gulf Coast, nearly killed him. "I started to get chills, feverish, my leg was swelling, burning," the third-generation sponge fisherman told CBS News. Billiris was wading in the water while fishing with his grandson back in July 2019 when he contracted the bacteria, which got into his system through a cut he had on his back leg. It was "just a little tiny scab," Billiris said. At the hospital, doctors used a marker on his leg to track the spread of the bacteria. After three weeks of treatment, the infection subsided, saving his leg from amputation. According to the Centers for Disease Control and Prevention, one in five people who contract the bacteria die after rapid spread of the infection. During hurricane season, the danger of contracting Vibrio vulnificus heightens, according to Dr. Valerie Harwood, a microbiologist at the University of South Florida. Research also shows the ocean's water temperature is rising due to climate change, which leads to more frequent and severe storms. Harwood said that because the bacteria thrives in warmer waters, it means more infections are seen in places that haven't experienced them before as water temperatures rise in those regions. "With warming waters, we are seeing cases further north," Harwood said. In recent years, cases have been reported in the Carolinas, and even as far north as Connecticut and New York. This year, there have been 17 cases in Louisiana, 16 in Florida and seven in North Carolina. Florida has reported five deaths so far, the most of any state. The bacteria can also spread through uncooked seafood, mainly oysters. These days, Billiris says he is more cautious in the water, but he still sails his family's boat nearly every day. He hopes others will recognize the symptoms of an infection, because earlier treatment could mean the difference between life and death. "Lot of people waited because they didn't know," he said. President Trump says meeting with Russia's Putin is not to broker peace deal in Ukraine Trump says he's placing D.C. police under federal control, deploying National Guard Could Tropical Storm Erin become the first Atlantic hurricane of 2025? Solve the daily Crossword
New York Times
40 minutes ago
- New York Times
Mentally Ill Detainees Are Trapped in Legal Limbo, Lawsuit Says
Hundreds of mentally ill detainees who were found unfit to stand trial are languishing in New York City's jails because the state has been too slow in moving them through its byzantine treatment system, a public defender organization said in a lawsuit filed Tuesday. Under New York State law, people who are too mentally ill to understand the charges against them and aid in their own defense are supposed to be restored to competency in a hospital operated by the state Office of Mental Health before their legal proceedings can continue. But bed and staffing shortages at the hospitals have led to long delays in people receiving the care, leaving them to linger amid disorder and dangerous conditions on Rikers Island, the suit said. A class action, it was filed by the Legal Aid Society and a New York University law clinic in Federal District Court in Manhattan. More than half the people in city custody are mentally ill, records show, and on any given day about 100 people are held on Rikers Island while awaiting transfer to be restored to competency, the suit said. The average wait time for a bed is about two and a half months, the suit said. Some wait longer: In 2024, 130 people spent more than 100 days on waiting lists for the treatment. In some cases, the long delays have proved fatal. At least five people who have died after being held on Rikers Island since 2021 had been ordered to be restored to competency, the suit said. Want all of The Times? Subscribe.
